For: | Hao ZM, Luo JY, Cheng J, Wang QY, Yang GX. Design of a ribozyme targeting human telomerase reverse transcriptase and cloning of it’s gene. World J Gastroenterol 2003; 9(1): 104-107 [PMID: 12508361 DOI: 10.3748/wjg.v9.i1.104] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v9/i1/104.htm |
Number | Citing Articles |
1 |
Xiao-dong GAO, Yi-rong CHEN. Inhibition of telomerase with human telomerase reverse transcriptase antisense enhances tumor necrosis factor-α-induced apoptosis in bladder cancer cells. Chinese Medical Journal 2007; 120(9): 755 doi: 10.1097/00029330-200705010-00004
|
2 |
Brian R. Keppler, Michael B. Jarstfer. A high-throughput assay for a human telomerase protein–human telomerase RNA interaction. Analytical Biochemistry 2006; 353(1): 75 doi: 10.1016/j.ab.2006.03.027
|
3 |
Georgios D. Ayiomamitis, George Notas, Apostolos Zaravinos, Ioannis Drygiannakis, Maria Georgiadou, Ourania Sfakianaki, Niki Mastrodimou, Kyriaki Thermos, Elias Kouroumalis. Effects of octreotide and insulin on colon cancer cellular proliferation and correlation with hTERT activity.. Oncoscience 2014; 1(6): 457 doi: 10.18632/oncoscience.58
|
4 |
Chun Li, Ming-Yao Wu, Ying-Rui Liang, Xian-Ying Wu. Correlation between expression of human telomerase subunits and telomerase activity in esophageal squamous cell carcinoma. World Journal of Gastroenterology 2003; 9(11): 2395-2399 doi: 10.3748/wjg.v9.i11.2395
|
5 |
Shan Gao, Bao-Ping Yu, Yan Li, Wei-Guo Dong, He-Sheng Luo. Antiproliferative effect of octreotide on gastric cancer cells mediated by inhibition of Akt/PKB and telomerase. World Journal of Gastroenterology 2003; 9(10): 2362-2365 doi: 10.3748/wjg.v9.i10.2362
|
6 |
Rong Guo, Ping Zou, Hua-Hua Fan, Feng Gao, Qing-Xin Shang, Yi-Lin Cao, Hua-Zhong Lu. Repression of allo-cell transplant rejection through CIITA ribonuclease P<sup>+</sup> hepatocyte. World Journal of Gastroenterology 2003; 9(5): 1077-1081 doi: 10.3748/wjg.v9.i5.1077
|
7 |
Xing Chen, Wen‐Jian Tang, Jing Bo Shi, Ming Ming Liu, Xin‐Hua Liu. Therapeutic strategies for targeting telomerase in cancer. Medicinal Research Reviews 2020; 40(2): 532 doi: 10.1002/med.21626
|